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There are numerous studies over 
the past few decades that reiterate 
the positive points of Obesity and 
Metabolic Surgery. It’s ability to 
provide a relatively more sustainable 
weight loss over a longer period of 
time, improvement in quality of life 
and weight-related comorbidities 
namely Type 2 Diabetes Mellitus are 
among a few to boast. However, as 
with any invasive procedure, Obesity 
and Metabolic Surgery is not free of 
possible complication risks, the main 
reason for which there has been a major 
push for improvements in efficacy and 
innovation for better and safer surgical 
weight loss options. In the era of 
“healthcare at your fingertips”, a simple 
Google search will be able to enlighten 
just anyone on the available options 
making it possible for an individual 
to “negotiate” or “bargain” with their 
surgeon before making a final decision. 
The four most well researched and 
documented weight loss procedures 
are Laparoscopic Sleeve Gastrectomy 
(LSG), Laparoscopic Roux-En-Y gastric 
Bypass (LRYGB), Biliopancreatic 
Diversion (BPD) and Laparoscopic 
Adjustable Gastric Banding (LAGB) 
(Buchwald et al. 2004). Look a little 
closer and you will not be able to turn 
away from being a tad bit curious about 
a few “new kids on the block” such 
as Laparoscopic Mini Gastric Bypass, 
Laparoscopic Sleeve Gastrectomy with 
Proximal Jejunal Bypass, Laparoscopic 
Banded Roux-En-Y Gastric Bypass and 
some of the less invasive endoluminal 
procedures including a recent FDA 
approved percutaneous aspiration 
device called Aspire Assist that has 
garnered much interest as well as 
criticism at the same time (Lee et 
al. 2014; Kumar 2016; Forssell & 
Norén 2015). Surgeons from all over 
the world, their institutions, and the 
supporting industry laud the excitement 
surrounding innovation in Obesity and 
Metabolic Surgery. A sentiment shared 
by consumers who perceive “new” as 
synonymous with improved.
 However, the speed of which the 
“Innovation Train” has been clocking 
in recent years has made many weiry, 
causing them take a step back and 
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to novel therapies boasts fantastic early 
outcome, with intermediate or long term 
data no where to be seen despite being 
in the market for more than 5 yrs. Poor 
outcome or unwarranted complications 
attributed to the rapid turnover of novel 
procedures especially those without 
rigorous or independent cross check 
mechanisms could pose a negative 
anddetrimental effect on health care 
access for  patients suffering with 
obesity and obesity related diseases. 
For a tiny developing country in South 
East Asia country like Malaysia, the 
end effect of such a catastrophe could 
plummet our healthcare economy. 
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look at the whole fiasco from a bird’s 
eye perspective. Would it not be more 
reasonable to delineate the mechanisms 
of existing bariatric procedures before 
new ones are pushed into the open? 
Better understanding of the relevant 
pathophysiology would allow design 
and redesign of future bariatric 
procedures to proceed and progress 
on a much more respectable and 
believable foundation. Walter Pories 
a world reknown, well respected and 
much loved Bariatric Surgeon with an 
flair for drawing brilliant cartoons about 
every day life as a surgeon, beautifully 
ilustrates this lack of understanding of 
the underlying mechanism of Obesity 
and Metabolic Surgery in a Cartoon 
(Figure 1).
 While it is undeniable and irrefutable 
that surgery is a valid option for 
treatment of obesity and obesity related 
metabolic syndrome, our knowledge of 
how bariatric procedures work needs 
much more “work” in itself. Many of the 
so-called “published reports” pertaining 
Figure 1: Walter Pories Cartoon (Carlson 2015)
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